Zetta Genomics

Zetta Genomics is a technologically advanced and ground-breaking company that specializes in genomic data management. The corporation operates in various fields such as genomic healthcare, biomedical research, and pharmaceutical R&D. Zetta Genomics' mission, driven by their dynamic team, is to release the full potential of genomic data to improve health outcomes for millions of patients worldwide and thereby realize the comprehensive possibilities of precision medicine. They ambition to make precision medicine accessible to everyone underlines their commitment towards global healthcare.

The company's cutting-edge product, XetaBase, is a genomic-native technology built on the open-source OpenCB software platform, designed to handle the scale, speed, and re-interpretation demands of genomic medicine. Zetta while developing XetaBase, had the support from remarkable institutes such as the University of Cambridge and Genomics England, providing it with a solid and trusted foundation. XetaBase is set apart by its abilities to facilitate tertiary analysis by aggregating, indexing, and enriching secondary genomic data. This pioneering technology allows for continual re-interpretation of this data, creating a vital resource for unlocking valuable research and clinical insights.

In conclusion, Zetta Genomics stands as a beacon in the field of genomic data management with the potential to revolutionize healthcare approaches. Zetta's value proposition lies in its unique technology XetaBase, which expedites the cost-effective application of genomic data leading to improved health outcomes. This organization's relentless pursuit of new and innovative approaches in facing complex problems, and fostering an environment of respect, collaboration, and innovation makes it an exciting and promising entity to follow and engage with in the healthcare and genomic data sectors.

Connect